| | 27741-01-1 Basic information More.. |
| Product Name: | Geniposidic acid | | Synonyms: | (1S,4aS,7aS)-7-(hydroxymethyl)-1-((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-tetrahydro-2H-pyran-2-yloxy)-1,4a,5,7a-tetrahydrocyclopenta[c]pyran-4-carboxylic acid;(1R,2S,6S)-9-(Hydroxymethyl)-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-oxabicyclo[4.3.0]nona-4,8-diene-5-carboxylic acid;GENIPOSIDIC ACID;Geniposidic acid std.;(1S)-1α-(β-D-Glucopyranosyloxy)-1,4aα,5,7aα-tetrahydro-7-hydroxymethylcyclopenta[c]pyran-4-carboxylic acid;(1S,4aS,7aS)-7-(Hydroxymethyl)-1-(β-D-glucopyranosyloxy)-1,4a,5,7a-tetrahydrocyclopenta[c]pyran-4-carboxylic acid;1α-(β-D-Glucopyranosyloxy)-1,4aα,5,7aα-tetrahydro-7-(hydroxymethyl)cyclopenta[c]pyran-4-carboxylic acid;GENIPOSIDIC ACID(SH) | | CAS: | 27741-01-1 | | MF: | C16H22O10 | | MW: | 374.34 | | EINECS: | | | Mol File: | 27741-01-1.mol |  |
Use
Geniposidic acid is an effective anticancer and radioprotection agent. Geniposidic acid might be a more potent tumor growth inhibitor than geniposide (GP) when combined with the X-irradiation, though there was no significant synergetic effect on their com
- Geniposidic acid
-
- 2026-06-30
- CAS:27741-01-1
- Min. Order: 1KG
- Purity: 98%
- Supply Ability: 1000kgs
- Geniposidic Acid
-
- $30.00
- 2026-05-11
- CAS:27741-01-1
- Purity: 97.60%
- Supply Ability: 10g
- Geniposidic acid
-
- 2023-02-24
- CAS:27741-01-1
- Min. Order: 5mg
- Purity: ≥98%(HPLC)
- Supply Ability: 10 g
|
|
27741-01-1
Recommend Suppliers |
| Company Name: |
Labnetwork lnc.
Recommend
Complaint |
 |
| Tel: |
+86-27-50766799 |
| FAX: |
|
| Email: |
contact@labnetwork.com |
| Nationality: |
China |
| Products Intro: |
Product Name:(1S,4aS,7aS)-7-(hydroxymethyl)-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1,4a,5,7a-tetrahydrocyclopenta[c]pyran-4-carboxylic acid CAS:27741-01-1 Purity:95% Package:100g; 1kg Remarks:LN01341835 |
| CB Index: |
58 |
| WebSite: |
www.labnetwork.com |
| Related Information: |
Sales Network
Catalog(19981)
User Evaluation
|
|
|
|
|
|